MICHELLE WILSON: Open Payments
NPI 1982053385 · BOONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 42 payments from 15 companies in 2025. Trend: 2023 $745 · 2024 $566 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $283 |
| PFIZER INC. | 3 | $50 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Medtronic, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
Products named: UBRELVY, QULIPTA, VRAYLAR, TRINTELLIX, MINIMED 780G, OTEZLA, PREVNAR 20, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
